Abstract: The present invention provides novel compositions comprising multipotent cells or microvascular tissue, wherein the cells or tissue has been sterilized and/or treated to inactivated viruses, and related methods of using these compositions to treat or prevent tissue injury or disease in an allogeneic subject.
Type:
Grant
Filed:
January 4, 2022
Date of Patent:
November 21, 2023
Assignee:
MicroVascular Tissues, Inc.
Inventors:
Dale R. Peterson, Ralph-Heiko Mattern, Kevin L Ohashi, Lael J. Pickett, Glen Gong, Mohammad A. El-Kalay
Abstract: The present invention provides novel compositions comprising multipotent cells or microvascular tissue, wherein the cells or tissue has been sterilized and/or treated to inactivated viruses, and related methods of using these compositions to treat or prevent tissue injury or disease in an allogeneic subject.
Type:
Grant
Filed:
June 26, 2017
Date of Patent:
August 4, 2020
Assignee:
MicroVascular Tissues, Inc.
Inventors:
Dale R. Peterson, Ralph-Heiko Mattern, Corey Wilson-Wirth, Kevin L. Ohashi
Abstract: The present invention provides novel compositions comprising multipotent cells or microvascular tissue, wherein the cells or tissue has been sterilized and/or treated to inactivated viruses, and related methods of using these compositions to treat or prevent tissue injury or disease in an allogeneic subject.
Type:
Grant
Filed:
January 2, 2018
Date of Patent:
April 14, 2020
Assignee:
MicroVascular Tissues, Inc.
Inventors:
Dale R. Peterson, Ralph-Heiko Mattern, Corey Wilson, Kevin L. Ohashi
Abstract: The present invention provides novel compositions comprising multipotent cells or microvascular tissue, wherein the cells or tissue has been sterilized and/or treated to inactivated viruses, and related methods of using these compositions to treat or prevent tissue injury or disease in an allogeneic subject.
Type:
Grant
Filed:
January 8, 2018
Date of Patent:
March 24, 2020
Assignee:
MicroVascular Tissues, Inc.
Inventors:
Dale R. Peterson, Ralph-Heiko Mattern, Kevin L. Ohashi, Lael J. Pickett, Glen Gong, Mohammad A. El-Kalay
Abstract: Disclosed are products and methods for treating soft tissue injuries. The provided methods include the production of processed or cryopreserved microvascular tissue. Also provided are products and methods of using processed or cryopreserved microvascular tissue for the treatment of soft tissue injuries.
Abstract: The present invention provides novel compositions comprising multipotent cells or microvascular tissue, wherein the cells or tissue has been sterilized and/or treated to inactivated viruses, and related methods of using these compositions to treat or prevent tissue injury or disease in an allogeneic subject.
Type:
Grant
Filed:
May 6, 2016
Date of Patent:
January 23, 2018
Assignee:
Microvascular Tissues, Inc.
Inventors:
Dale R. Peterson, Ralph-Heiko Mattern, Cory Wilson-Wirth, I, Kevin L. Ohashi
Abstract: The present invention provides novel compositions comprising multipotent cells or microvascular tissue, wherein the cells or tissue has been sterilized and/or treated to inactivated viruses, and related methods of using these compositions to treat or prevent tissue injury or disease in an allogeneic subject.
Type:
Grant
Filed:
September 17, 2013
Date of Patent:
July 25, 2017
Assignee:
MicroVascular Tissues, Inc.
Inventors:
Dale R. Peterson, Ralph-Heiko Mattern, Corey Wilson-Wirth, Kevin L. Ohashi
Abstract: Disclosed are products and methods for treating soft tissue injuries. The provided methods include the production of processed or cryopreserved microvascular tissue. Also provided are products and methods of using processed or cryopreserved microvascular tissue for the treatment of soft tissue injuries.